Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for cryosurgery of the prostate, effective May 15, 2026. Here's what billing teams need to do.
CMS updated its cryosurgery of prostate coverage policy — a procedure that has seen shifting medical necessity standards for years. This policy does not list specific CPT, HCPCS, or ICD-10 codes in the available data, so your billing team should pull the current policy directly from the CMS source to confirm affected codes. The effective date of May 15, 2026 gives you a hard deadline to audit claims, verify documentation requirements, and update your workflows before denials start hitting your AR.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS |
| Policy | Cryosurgery of Prostate |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Urology, Oncology, Radiation Oncology |
| Key Action | Review documentation and prior authorization requirements against updated medical necessity criteria before May 15, 2026 |
CMS Cryosurgery of Prostate Coverage Criteria and Medical Necessity Requirements 2026
CMS has modified its cryosurgery of prostate coverage policy, and the real issue here is medical necessity. CMS coverage for cryosurgical ablation of the prostate has historically been one of the more contested areas in urology billing — not because the procedure is rare, but because the criteria for what constitutes covered versus non-covered use have been drawn and redrawn over the years.
Cryosurgery of the prostate involves using extreme cold to destroy prostate tissue. CMS has long distinguished between primary cryoablation — used as a first-line treatment for localized prostate cancer — and salvage cryoablation, used after radiation therapy fails. Those two indications have historically carried different coverage rules, and this modification may shift where those lines fall.
Because no specific code data or detailed criteria text is available in the current policy record, the Centers for Medicare & Medicaid Services has not published granular indication-level breakdowns through this source. Pull the full policy directly at the CMS source before May 15, 2026 to get the exact criteria language. If your practice bills a high volume of cryoablation claims, talk to your compliance officer now — not after the effective date.
The broader pattern here is familiar. This looks like the same kind of tightening CMS applied to high-intensity focused ultrasound (HIFU) for prostate cancer — where coverage existed in narrow windows and documentation had to be airtight to avoid claim denial. Cryosurgery of prostate billing has always required precise clinical justification. This modification likely raises that bar.
Prior authorization requirements may apply depending on your Medicare Administrative Contractor. MAC-level local coverage determinations can add requirements beyond the national policy. Check with your MAC before assuming the national policy covers your specific patient population.
CMS Cryosurgery of Prostate Exclusions and Non-Covered Indications
CMS has historically treated several uses of prostate cryosurgery as non-covered or experimental. Understanding where those lines sit matters for your reimbursement rate and your denial rate.
Repeated cryosurgery — a second cryoablation after a first has already been performed — has generally not been covered under Medicare. CMS has not viewed repeat procedures as meeting medical necessity without substantial clinical evidence of benefit, and that standard is unlikely to soften with this modification.
Prophylactic cryosurgery, where the goal is cancer prevention rather than treatment of documented disease, has also sat firmly in non-covered territory. Billing for prostate cryoablation in the absence of a confirmed prostate cancer diagnosis will result in claim denial, full stop.
Use in metastatic prostate cancer — where the disease has spread beyond the gland — has generally been considered outside the covered indications. CMS coverage for cryosurgery of the prostate has focused on localized disease. Billing for cryoablation in a patient with documented metastatic disease is a high-risk claim without strong supporting documentation and, likely, a specific MAC policy covering that scenario.
Because the specific updated exclusion criteria are not available in this policy record, verify the exact non-covered indications in the full policy document before May 15, 2026.
Coverage Indications at a Glance
The policy data available does not include a detailed indication-level breakdown. The table below reflects CMS's historical coverage positions on cryosurgery of the prostate. Verify each row against the updated policy text before the effective date of May 15, 2026.
| Indication | Status | Notes |
|---|---|---|
| Primary cryoablation for localized prostate cancer | Covered (historically) | Requires documented localized disease; verify updated criteria |
| Salvage cryoablation after radiation therapy failure | Covered (historically, with conditions) | Typically requires documented recurrence post-radiation; prior auth may apply |
| Repeat cryosurgery | Not Covered (historically) | Second procedures generally not covered under Medicare |
| Cryosurgery for metastatic prostate cancer | Not Covered (historically) | Outside localized disease indication |
| Prophylactic cryosurgery | Not Covered | No confirmed cancer diagnosis = no coverage |
| Cryosurgery as investigational use | Experimental / Not Covered | Clinical trials may apply; check MAC LCD |
Note: This table reflects historical CMS positions. The modified policy effective May 15, 2026 may alter any of these. Pull the full policy text to confirm current status for each indication.
CMS Cryosurgery of Prostate Billing Guidelines and Action Items 2026
Here's what to do before May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Pull the full updated policy from CMS. The available policy record does not include specific CPT or HCPCS codes. Go directly to the CMS source and get the actual policy document. Your billing team cannot act on a title alone. The source link for this policy is https://app.payerpolicy.org/p/cms/123-v1. |
| 2 | Contact your MAC for any applicable local coverage determination. National CMS policy sets the floor. Your MAC may have an LCD that adds prior authorization requirements or tightens criteria for your region. Don't assume the national policy is the whole story. |
| 3 | Audit your current prostate cryosurgery claims. Pull claims from the last 12 months. Look at how you're documenting medical necessity — specifically, whether your documentation distinguishes between primary and salvage cryoablation, confirms localized disease, and ties the procedure to the correct diagnosis codes. This audit will show you where your exposure is. |
| 4 | Update your charge capture and documentation templates before May 15, 2026. If the modified criteria change what documentation CMS requires, your providers need to know before the effective date — not after a wave of denials lands in your AR. Work with your medical director or a billing consultant to revise your templates now. |
| 5 | Review prior authorization workflows. Whether cryosurgery of the prostate requires prior authorization under Medicare depends on your MAC and plan. Confirm this before May 15, 2026. If prior auth is required and your team isn't capturing it, every claim you submit without it is a denial waiting to happen. |
| 6 | Flag high-risk patients proactively. If you have patients scheduled for prostate cryoablation after May 15, 2026, review their records now against the updated criteria. This is especially true for patients who would be billed under salvage indications or who have had a prior cryoablation. Getting ahead of eligibility issues before the procedure happens is far easier than appealing denials after the fact. |
| 7 | Consult your compliance officer if you're unsure about your mix. If your practice does significant volume in cryosurgery of the prostate — particularly salvage procedures or off-label uses — this modification warrants a compliance review. Talk to your compliance officer before May 15, 2026. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Cryosurgery of Prostate Under This Policy
The policy data available for this modification does not include specific CPT, HCPCS, or ICD-10 codes. PayerPolicy does not fabricate codes, and you should not rely on any source that does.
What Your Billing Team Should Do
Pull the full CMS policy document directly using the source link provided. CPT codes associated with prostate cryosurgery billing are well-established in the urology coding space, but the specific codes covered, excluded, or modified under this updated policy must come from the policy text itself — not from a third-party summary.
Cross-reference any codes you currently use for cryosurgical ablation of the prostate against the updated policy criteria before submitting claims on or after May 15, 2026.
If you do not have access to a certified coder with urology experience, this is a good moment to bring one in. The difference between a covered and non-covered claim in prostate cryoablation often comes down to one or two diagnosis codes and a documentation sentence. Get it right before the effective date.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.